Skip to content
drillr.ai
Sign up

INMB

INmune Bio, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.44
+7.49%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—50.0K14.0K155.0K374.0K
Cost of Revenue108.0K————
Gross Profit(108.0K)50.0K14.0K155.0K374.0K
Operating Expenses
R&D Expense11.7M20.7M33.2M20.3M17.1M
SG&A Expense10.3M10.3M9.5M9.6M9.3M
General & Admin Expense10.1M10.3M9.5M9.6M9.3M
Selling & Marketing Expense134.0K————
Other Expenses(1.8M)————
Total Operating Expenses20.1M30.9M42.6M29.9M26.3M
Cost and Expenses20.2M30.9M42.6M29.9M26.3M
Operating Income (EBIT)(20.2M)(30.9M)(42.6M)(29.7M)(26.0M)
Non-Operating
Interest Income210.0K850.0K———
Interest Expense—————
Net Interest Income210.0K850.0K———
Other Non-Op Income/Expense1.8M(15.1M)553.0K(267.0K)(1.3M)
Non-Operating Income (excl Interest)(1.8M)15.1M(553.0K)267.0K1.3M
EBT (Pre-Tax Income)(18.4M)(45.9M)(42.1M)(30.0M)(27.3M)
Income Tax Expense—————
Bottom Line
Net Income(18.4M)(45.9M)(42.1M)(30.0M)(27.3M)
Earnings from Cont. Ops(18.4M)(45.9M)(42.1M)(30.0M)(27.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(18.4M)(45.9M)(42.1M)(30.0M)(27.3M)
Per Share
Basic EPS($0.69)($1.86)($2.11)($1.67)($1.52)
Diluted EPS($0.69)($1.86)($2.11)($1.67)($1.52)
Revenue Per Share$0.00$0.00$0.00$0.01$0.02
Shares
Basic Shares Outstanding26.7M26.6M19.9M18.0M17.9M
Diluted Shares Outstanding26.7M26.6M19.9M18.0M17.9M
Profitability Metrics
EBITDA(18.2M)(45.8M)(41.5M)(267.0K)(1.3M)
D&A208.0K84.0K553.0K29.7M26.0M
EBIT(18.4M)(45.9M)(42.1M)(30.0M)(27.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026